Given Imaging
This article was originally published in The Gray Sheet
Executive Summary
Proposed initial public offering likely will help support commercialization of the Israeli firm's Given swallowable camera microcapsule. Wireless endoscopy diagnostic imaging system gained 510(k) clearance Aug. 1 as an adjunctive tool to visualize the inside of the small intestines to detect polyps, cancer or causes of bleeding (1"The Gray Sheet" Aug. 6, 2001, In Brief). The number of shares and aggregate value of the offering, anticipated to occur by year-end, have not yet been determined. The firm is preparing to file a registration statement with the SEC
You may also be interested in...
Given camera pill
Given Imaging's swallowable capsule for visualizing the inside of the small intestine to detect polyps, cancer or causes of bleeding gains FDA market go-ahead Aug. 1 via agency's 510(k) de novo process. The diagnostic imaging system is intended for use in conjunction with other endoscopic or radiological examinations. The capsule incorporates a small camera, lights, image transmitter and eight-hour battery (1"The Gray Sheet" July 30, 2001, p. 14)
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.